Pharmaktiv acquired remaining 51% stake in Endogenix LLC from Gan & Lee Pharmaceuticals..
Pharmaktiv completed the acquisition of remaining 51% stake in Endogenix LLC from Gan & Lee Pharmaceuticals. (SHSE:603087) on June 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
48.4 CNY | -0.51% | -0.98% | -8.07% |
1st Jan change | Capi. | |
---|---|---|
-8.07% | 397.48Cr | |
-3.36% | 9.04TCr | |
+3.95% | 4.14TCr | |
-10.51% | 3.36TCr | |
+60.58% | 2.57TCr | |
-20.09% | 1.47TCr | |
-8.92% | 1.28TCr | |
-11.46% | 1.17TCr | |
-43.05% | 1.14TCr | |
+5.17% | 879.22Cr |